Current options for the prevention and treatment of migraine

Clinical Therapeutics

Volumn 23, Issue 6, 2001, Pages 772-788

  Adelman, James U ^a   Adelman, Richard D ^b  

^a Headache Wellness Center   (United States)

^b Private Practice   (United States)

Author keywords

Analgesic; Headache; Migraine; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTALBITAL PLUS ASPIRIN PLUS CAFFEINE PLUS CODEINE; BUTORPHANOL; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; COCODAMOL; DICLOFENAC POTASSIUM; DIHYDROERGOTAMINE; ERGOTAMINE; ERGOTAMINE PLUS CAFFEINE PLUS PENTOBARBITAL PLUS BELLADONNA; FLURBIPROFEN; GRANISETRON; IBUPROFEN; ISOMETHEPTENE; KETOROLAC; LIDOCAINE; METHADONE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; PETHIDINE; PROCHLORPERAZINE; RIZATRIPTAN; SEROTONIN 1B ANTAGONIST; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

DIARRHEA; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; EATING; HUMAN; JOB PERFORMANCE; LIFESTYLE; MIGRAINE; PROPHYLAXIS; REVIEW; RISK FACTOR; SLEEP; TREATMENT PLANNING; VOMITING;

EID: 0034979460     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80069-2     Document Type: Article

References (61)

1. Canadian Association of Emergency Physicians guidelines for the acute management of migraine headache
2. Diagnosis and symptomatic treatment of migraine
3. An overview of the diagnosis and pharmacologic treatment of migraine
4. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
5. The family history of migraine. Direct versus indirect information
6. A nosographic analysis of the migraine aura in a general population
7. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache
8. Medication-induced headache: Overview and systematic review of therapeutic approaches
9. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial
10. Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study
11. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
12. Magnesium in the prophylaxis of migraine - A double-blind placebo-controlled study
13. Feverfew as a preventive treatment for migraine: A systematic review
14. Anti-migraine drugs
15. Migraine prophylactic drugs: Proof of efficacy, utilization and cost
16. Guidelines on migraine: Part 5. Recommendations for specific prophylactic drugs
17. Migraine: Diagnosis and rational treatment
18. Venlafaxine extended release (XR) for prophylaxis of migraine and tension-type headaches: A retrospective study in a clinical setting
19. Divalproex sodium in migraine prophylaxis: A dose-controlled study
20. Efficacy of gabapentin in migraine prophylaxis
21. Topiramate for migraine prophylaxis: A double-blind, randomized, placebo-controlled study
22. Methysergide
23. Imitrex injection
24. Imitrex nasal spray
25. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine
26. Imitrex tablets
27. Zomig tablets
28. Maxalt tablets, Maxalt-MLT orally disintegrating tablets
29. Rizatriptan in the treatment of migraine
30. Amerge tablets
31. Naratriptan: An alternative for migraine
32. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine
33. Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine
34. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine
35. Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
36. The first comparison of the efficacy and safety of 311C90 and sumatriptan in the treatment of migraine
37. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine
38. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?
39. How to assess and compare drugs in the management of migraine: Success rates in terms of response and recurrence
40. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan
41. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial
42. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache
43. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache
44. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
45. Triptans and migraine
46. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels
47. Treatment of severe, disabling-migraine attacks in an over-the-counter population of migraine sufferers: Results from three randomized, placebo controlled studies of combination of acetaminophen, aspirin, and caffeine
48. Stratified care vs step care strategies for migraine. The Disability in Strategies of Care (DISC) study: A randomized trial
49. Acute treatment of migraine attacks: Efficacy and safety of a non-steroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo
50. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: A randomized, double-blind, placebo-controlled, dose-ranging study
51. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks
52. A practical guide to the management and prevention of migraine
53. Prevention of migraine during prodrome with naratriptan
54. Treatment of mild pain with sumatriptan in the spectrum of headaches in patients with disabling IHS migraine
55. Migraine attack treatment with rizatriptan: Timing of the medication use and clinical outcomes
56. Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials
57. Symptomatic pharmacotherapy of migraine